每经AI快讯，1月8日，脑机接口板块高开，创新医疗4连板创新高，爱朋医疗、南京熊猫、海南海药、 岩山科技、菲沃泰跟涨。 （文章来源：每日经济新闻） ...

Core Insights - Innovation Medical (002173) has seen a stock price increase of 9.99%, closing at 28.63 yuan, marking three consecutive days of limit-up trading [1] - The company reported a net inflow of 130 million yuan from institutional investors, accounting for 44.76% of the total trading volume on January 7 [1] - The company's main business involves providing medical services [2] Financial Performance - For the first three quarters of 2025, Innovation Medical reported a main revenue of 597 million yuan, a year-on-year decrease of 2.11% [2] - The net profit attributable to shareholders was 4.72 million yuan, showing a significant year-on-year increase of 116.97% [2] - The third quarter of 2025 saw a main revenue of 196 million yuan, down 3.16% year-on-year, while the net profit attributable to shareholders rose by 236.15% to 16.09 million yuan [2] Financing and Margin Trading - On January 7, the company had a financing buy of 8.60 million yuan and a financing repayment of 15.90 million yuan, resulting in a net repayment of 7.29 million yuan [1] - The margin trading balance stood at 290 million yuan, with a short selling balance of 406,500 yuan [1]

Policy Developments - The National Medical Products Administration (NMPA) is optimizing the review and approval process for urgently needed overseas drugs that have already been marketed, aiming to meet the pressing clinical needs of patients [1] Drug and Device Approvals - Yifan Pharmaceutical's subsidiary received a registration acceptance notice for Yihuang Decoction Granules, which is indicated for kidney strengthening and dampness clearing [2] - Zhenghai Bio announced that it received a medical device registration acceptance notice for a uterine cavity repair membrane, currently in the acceptance stage [3] - Microchip Biotech's Xidabendan Tablets have been approved for sale in Macau, marking an expansion into overseas markets [4] - Heng Rui Medicine's innovative drug Ruirafulpu α injection has been approved for marketing, with no similar products currently approved domestically or internationally, and a cumulative R&D investment of approximately 711 million yuan [5] Capital Market Insights - Bibet reported that it is not yet profitable and has accumulated unremedied losses, with only one product approved and several others in various clinical trial stages, indicating a need for significant ongoing R&D investment [6] - Innovation Medical confirmed that its production and operational status is normal, with no undisclosed significant matters [7][8] Industry Events - Yiming Onco announced the termination of its collaboration agreement with Axion Bio, regaining global development and commercialization rights for two core anti-cancer drugs, with previously received payments unaffected [9] Public Opinion Alerts - The Director of the Jiangxi Provincial Health Commission is under disciplinary review and investigation for serious violations of discipline and law [10]

截至2026年1月7日收盘，创新医疗（002173）报收于28.63元，较前一交易日上涨9.99%，最新总市值为 126.34亿元。该股当日开盘28.63元，最高28.63元，最低28.63元，成交额达2.91亿元，换手率为2.44%。 公司近日发布公告称，创新医疗管理股份有限公司股票（证券简称：创新医疗，股票代码：002173）于 2026年1月5日、6日、7日连续三个交易日内日收盘价格涨幅偏离值累计超过20%，构成交易异常波动。 公司对控股股东、实际控制人及董事高管进行核实，确认前期披露信息无误，未发现重大未披露信息， 近期生产经营情况及内外部环境未发生重大变化，控股股东及实际控制人在异常波动期间未买卖公司股 票。董事会确认无应披露而未披露事项，公司指定信息披露媒体为《证券时报》《上海证券报》《证券 日报》《中国证券报》及巨潮资讯网。 最新公告列表 《股票交易异常波动公告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

| 1月7日涨停封单资金居前的个股 | | --- | | 代码 | 名称 | 涨停封单额 | 涨停板 | 涨停原因 | | --- | --- | --- | --- | --- | | | | (亿元) | 情況 | | | 002195 | 岩山科技 | 19.46 | 3连板 | 脑机接口+Yan大模型+2345导航 | | 002931 | 锋龙股份 | 15.49 | 9连板 | 优必选拟入主+机器人+复牌 | | 600783 鲁信创投 | | 10.76 | 9日7板 | 蓝箭航天IPO+人工智能基金+山东国资 | | 002173 | 创新医疗 | 10.29 | 3连板 | 脑机接口+民营医院+高压氧舱 | | 600775 南京熊猫 | | 5.80 | 3连板 | 脑机接口+卫星通信+智能制造+央企 | | 002774 | 快意电梯 | 4.22 | 3连板 | 一带一路+旧梯更新+电梯制造 | | 000620 | 盈新发展 | 3.91 | 2连板 | 拟收购半导体+存储芯片+文旅地产 | | 600435 | 北方导航 | 3.44 | 2连板 | 卫星通信+军工制导+央企 | ...

每经AI快讯，1月7日，Wind数据显示，A股市场共计98只个股涨停。机器人板块锋龙股份9连板；商业 航天板块雷科防务6连板、城建发展4连板；脑机接口板块多股连板，创新医疗、岩山科技等3连板。 每经AI快讯，1月7日，Wind数据显示，A股市场共计98只个股涨停。机器人板块锋龙股份9连板；商业 航天板块雷科防务6连板、城建发展4连板；脑机接口板块多股连板，创新医疗、岩山科技等3连板。 ...

创新医疗(002173.SZ)公告称，公司股票于2026年1月5日至7日连续三个交易日内收盘价格涨幅偏离值累 计超过20%，属于股票交易异常波动情形。经核实，公司前期披露的信息不存在需要更正、补充之处， 近期公司生产经营情况及内外部经营环境未发生重大变化，公司、控股股东及实际控制人不存在应披露 而未披露的重大事项。公司提醒广大投资者理性投资，注意投资风险。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

证券之星消息，1月7日医疗服务板块较上一交易日上涨1.7%，益诺思领涨。当日上证指数报收于 4085.77，上涨0.05%。深证成指报收于14030.56，上涨0.06%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 688710 | 益诺思 | 55.31 | 20.00% | 5.97万 | | 3.17亿 | | 688222 | 成都先导 | 30.44 | 13.67% | 44.49万 | | 13.43亿 | | 301293 | 三博脑科 | 93.82 | 10.45% | 74.53万 | | 68.62亿 | | 002173 | 创新医疗 | 28.63 | 9.99% | 10.16万 | | 2.91亿 | | 688621 | 阳光诺和 | 72.10 | 7.77% | 6.88万 | | 4.95 乙 | | 603127 | 昭衍新药 | 41.30 | 7.41% | 36.68万 | | 14.97亿 | | ...

钛媒体App 1月7日消息，创新医疗公告称，公司股票于2026年1月5日至7日连续三个交易日内收盘价格 涨幅偏离值累计超过20%，属于股票交易异常波动情形。经核实，公司前期披露的信息不存在需要更 正、补充之处，近期公司生产经营情况及内外部经营环境未发生重大变化，公司、控股股东及实际控制 人不存在应披露而未披露的重大事项。公司提醒广大投资者理性投资，注意投资风险。（公司公告） ...

创新医疗1月7日发布公告，公司股票于2026年1月5日至7日连续三个交易日内收盘价格涨幅偏离值累计 超过20%，属于股票交易异常波动情形。经核实，公司前期披露的信息不存在需要更正、补充之处，近 期公司生产经营情况及内外部经营环境未发生重大变化，公司、控股股东及实际控制人不存在应披露而 未披露的重大事项。公司提醒广大投资者理性投资，注意投资风险。 ...